Drug trial led by Cincinnati researchers gains national media attention

Dr. Evan Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati, is leading clinical trials for a new drug candidate (REGN727) that may do a better job of lowering cholesterol than statins, and with fewer side effects. The New York Times and ABC News took notice last month.

Dr. Evan Stein

Study results were published in a recent issue of The New England Journal of Medicine.

“About 5 to 10 percent of people can’t tolerate statins at all, and more can’t tolerate higher doses,” said Dr. Evan A. Stein, director of the Metabolic and Atherosclerosis Research Center in Cincinnati and lead author of the drug trials. “It’s still early in development, but for them this is potentially a most promising alternative.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Norwood Medical in Dayton planning $13.5M expansion, adding 50 jobs | Dayton Business Journal, September 17, 2014

Youngstown Business Incubator and TechColumbus 1st and 3rd university associated incubators in the world | UBI Index, September 16, 2014

Enable Injections featured in article on safer, simpler, smarter devices for drug delivery | Drug Development & Delivery, September 15, 2014

BioOhio takes 2014 Annual Conference “on the road” in series of three regional events | Business Wire, September 15, 2014

ABC’s of IND’s – ChanTest to Host Session at the Safety Pharmacology Society (SPS) Annual Meeting | PR Web, September 15, 2014

Nationwide Children’s Hospital discusses Enterovirus D68 | Nationwide Children's Hospital, September 12, 2014

Akebia Therapeutics (NASDAQ: AKBA) to ring the NASDAQ Stock Market Opening Bell | NASDAQ, September 11, 2014

$1M grant to Cincinnati Children’s intended to improve human growth and development around the world | CCHMC, September 10, 2014

Airway Therapeutics gets money to advance treatment for smallest and sickest babies | WCPO9 Cincinnati, September 10, 2014

Airway Therapeutics raises $4.6M in Series A financing | CincyTech, September 10, 2014

Airway Therapeutics announces $4.6M funding round | Cincinnati.com, September 10, 2014

Alkermes anti-addiction drug Vivitrol helping inmates at Barnstable County Correctional Facility (MA) | Boston Business Journal, September 8, 2014

Nationwide Children’s Hospital now home to the world’s largest Ronald McDonald House | Columbus Dispatch, September 8, 2014

Envision Pharmaceutical completes its acquisition of MedTrak Services (Kansas) | Herald Online, September 8, 2014

Ohio Capital Fund key player in state startup scene | Cincinnati.com, September 6, 2014

Navidea enters Lymphoseek development and commercialization agreement with Hainan Sinotau Pharmaceutical Co., Ltd. subsidiary in China | Navidea Pharmaceuticals, September 4, 2014

Ricerca Biosciences in discussions to be acquired | OutsourcingPharma.com, September 3, 2014

Meridian Bioscience signs agreement with Premier to offer its hospitals molecular diagnostic tests and instruments | Business Wire, September 3, 2014

Cleveland Functional Electrical Stimulation Center taking toy donations at Expo to help disabled children | WKYC3 NBC, September 2, 2014

Aerpio Therapeutics announces publication of preclinical data on AKB-9778 for common eye diseases | Business Wire, September 2, 2014